Long‐term analysis of phase II studies of single‐agent lenalidomide in relapsed/refractory mantle cell lymphoma
暂无分享,去创建一个
T. Habermann | K. Takeshita | J. Drach | T. Witzig | J. Tuscano | A. Goy | R. Ramchandren | T. Fu | S. Kalayoğlu Beşışık | Marie‐Laure Casadebaig Bravo | Lei Zhang | P. Luigi zinzani